The UK health authorities are advising women taking GLP-1 weight loss drugs, like Ozempic and Mounjaro, to ensure they use effective contraceptives. This comes after over 40 reports linking these medications to pregnancy-related issues.
The situation has stirred conversations around unplanned pregnancies even among those on the pill, leading to what’s being dubbed “Ozempic baby.” So if you’re focused on shedding pounds instead of gaining a baby bump, it’s crucial to understand the implications of GLP-1 medications and the suitable birth control methods to consider.
Understanding GLP-1
There are several GLP-1 medications available today, primarily Ozempic and Wegovy, both featuring semaglutide. This ingredient mimics natural hormones that help to increase insulin levels, slow down digestion, and control appetite.
Other options include Saxenda and Viktosa, which contain liraglutide, functioning similarly to those first two.
Additionally, newer drugs like Mounjaro and Zepbound employ tilzepatide, which focuses on a second hormone essential for appetite and blood sugar regulation.
Unexpected Consequences
While common side effects of GLP-1 medications include nausea, vomiting, and diarrhea, an unexpected one gaining attention is the occurrence of pregnancies.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has reported 28 pregnancy-related cases tied to tilzepatide, with similar reports for semaglutide and liraglutide.
This week, authorities issued a caution: tilzepatide may diminish the effectiveness of oral contraceptives, especially in women with higher body weights. Hence, they’ve suggested utilizing barrier methods like condoms when taking drugs such as Mounjaro.
Currently, there’s no evidence that GLP-1 medications impact non-oral contraceptive methods like IUDs or implants. Also, this recommendation applies to even those who have previously faced infertility issues; GLP-1 is known to enhance fertility by promoting weight loss and better insulin sensitivity.
Is GLP-1 Safe During Pregnancy?
Experts generally advise against the use of GLP-1 drugs during pregnancy, primarily due to a lack of sufficient data on their safety.
Some studies suggest no harm in early pregnancy, but animal research indicates potential risks including miscarriages and birth defects.
Furthermore, these medications can suppress appetite and disturb gastrointestinal function, which are additional reasons to avoid their use during pregnancy.
It’s also recommended to refrain from using these drugs while breastfeeding due to inadequate safety research regarding infants.
Planning for Pregnancy? Check This Timeline
If you’re considering pregnancy, the MHRA suggests discontinuing GLP-1 medications prior to conception to allow them to clear from your system.
If you’re using semaglutide, you should stop at least two months before trying to conceive.
For tilzepatide, a month is recommended, while liraglutide clears more quickly, allowing you to stop just before attempting to get pregnant.
